Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 631.29 | 628.61 | 564.93 | 470.94 |
Depreciation/ Depletion | 53.45 | 42.09 | 37.88 | 33.39 |
Non- Cash Items | 37.84 | 8.99 | 39.89 | 100.35 |
Changesin Working Capital | -309.06 | -366.29 | -45.11 | -216.57 |
Cashfrom Operating Activities | 413.52 | 313.40 | 597.59 | 388.11 |
Capital Expenditures | -128.97 | -170.20 | -132.17 | -67.99 |
Other Investing Cash Flow Items Total | 12.49 | 16.05 | 9.94 | -0.74 |
Cashfrom Investing Activities | -116.48 | -154.15 | -122.23 | -68.73 |
Financing Cash Flow Items | -1.55 | -0.03 | -0.07 | - |
Total Cash Dividends Paid | -275.69 | -385.92 | -128.65 | - |
Issuance( Retirement)of Debt Net | -2.21 | -1.64 | -961.92 | -213.78 |
Cashfrom Financing Activities | -279.44 | -387.59 | -78.80 | -213.78 |
Net Changein Cash | 17.59 | -228.33 | 396.56 | 105.60 |
Cash Interest Paid | 1.55 | 0.03 | 0.07 | - |
Cash Taxes Paid | 162.96 | 153.57 | 138.17 | 108.56 |
Issuance( Retirement)of Stock Net | - | 0.00 | 1,011.85 | 0.00 |
Glenmark Life Sciences Dividend Glenmark Life Sciences Bonus Glenmark Life Sciences News Glenmark Life Sciences AGM Glenmark Life Sciences Rights Glenmark Life Sciences Splits Glenmark Life Sciences Board Meetings Glenmark Life Sciences Key Metrics Glenmark Life Sciences Shareholdings Glenmark Life Sciences Profit Loss Glenmark Life Sciences Balance Sheet Glenmark Life Sciences Q1 Results Glenmark Life Sciences Q2 Results Glenmark Life Sciences Q3 Results Glenmark Life Sciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks